HEMATOLOGICAL PROFILE OF COVID-19 POSITIVE PATIENTS IN QUETTA, PAKISTAN
Main Article Content
Keywords
COVID 19, Clinical Symptoms, hematological, SARS-CoV-2, critical
Abstract
In this study, the clinical symptoms and hematological variations of COVID-19 patients were assessed on the first day of examination. The patients were grouped on the basis of their admission to the Intensive Care Units (ICU) "Severe," High Dependency Units (HDU) "Moderate," or General Ward (Mild) of Fatima Jinnah Hospital, Quetta, Balochistan. The levels of leucocytes, neutrophils, lymphocytes, erythrocytes, hemoglobin, hematocrit, mean cell volume and MCHC in the blood upon their first medical examination day were retrieved from medical records of first day laboratory tests. These parameters are good indicators to gauge the course of the disease, protection against further body deterioration, reducing morbidity and mortality. The results of hematological profile revealed that there was an increase in neutrophils in moderate (76.58±1.78%), severe (76.07±2.52%) and critical (82.35±1.39%) groups while there was a decrease in lymphocytes in moderate (16.31±1.43%), severe (17.21±2.11%) and critical (12.74±1.25%) groups. There was an elevation in WBCs level of severe (11.38±0.88/L) and critical class (12.00±0.79/L). However, there was decrease in the hemoglobin (12.50±0.34 g/dL), hematocrit (34.10±0.97%), MCH (26.03±0.61 pg) and MCHC (29.58±0.73 g/dL) level of critical class. All the above results were showing significant difference (p<0.05) with non-COVID group.
References
2. Alfadda, A. A., et al. (2022). "Clinical and biochemical characteristics of people experiencing post-coronavirus disease 2019-related symptoms: A prospective follow-up investigation." Frontiers in medicine 9: 1067082.
3. Bari, A., et al. (2021). "Is leukopenia and lymphopenia a characteristic feature of COVID-19 in children?" Pakistan Journal of Medical Sciences 37(3): 869.
4. Cai, Q., et al. (2020). "COVID-19: Abnormal liver function tests." Journal of hepatology 73(3): 566-574.
5. Dubey, D. B., et al. (2021). "Hematological and serum biochemistry parameters as a prognostic indicator of severally ill versus mild Covid-19 patients: A study from tertiary hospital in North India." Clinical epidemiology and global health 12: 100806.
6. Esfahanian, F., et al. (2021). "Predictors of hospital mortality among patients with COVID-19 in Tehran, Iran." SAGE Open Medicine 9: 20503121211051573.
7. Huang, C., et al. (2020). "Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China." The lancet 395(10223): 497-506.
8. Hundt, M. A., et al. (2020). "Abnormal liver tests in COVID‐19: a retrospective observational cohort study of 1,827 patients in a major US hospital network." Hepatology 72(4): 1169-1176.
9. Ikram, S., et al. (2022). "Clinical and Biochemical indexes from 2019-nCoV infected Patients linked to Viral Loads and Lungs injury." Pakistan Journal of Chest Medicine 28(4): 484-490.
10. Illg, Z., et al. (2021). "Analysis of absolute lymphocyte count in patients with COVID-19." The American journal of emergency medicine 46: 16-19.
11. Kronstein-Wiedemann, R., et al. (2022). "SARS-CoV-2 infects red blood cell progenitors and dysregulates hemoglobin and iron metabolism." Stem cell reviews and reports 18(5): 1809-1821.
12. Lazarian, G., et al. (2020). "Autoimmune haemolytic anaemia associated with COVID‐19 infection." British journal of haematology 190(1): 29.
13. Lechuga, G. C., et al. (2023). "Hematological alterations associated with long COVID-19." Frontiers in Physiology 14: 1203472.
14. Liang, P., et al. (2024). "Predictive value of hematocrit, serum albumin level difference, and fibrinogen-to-albumin ratio for COVID-19-associated acute respiratory failure." Heliyon.
15. Mao, J., et al. (2021). "Hematologic changes predict clinical outcome in recovered patients with COVID-19." Annals of hematology 100(3): 675-689.
16. Nakanishi, H., et al. (2020). "Differential diagnosis of COVID-19: importance of measuring blood lymphocytes, serum electrolytes, and olfactory and taste functions." The Tohoku journal of experimental medicine 252(2): 109-119.
17. Palladino, M. (2021). "Complete blood count alterations in COVID-19 patients: A narrative review." Biochemia medica 31(3): 0-0.
18. Pourfridoni, M., et al. (2021). "Fluid and electrolyte disturbances in COVID‐19 and their complications." BioMed Research International 2021(1): 6667047.
19. QinC, Z. (2020). "Dysregulation of immune response in patients with COVID-19 in Wuhan, China." Clin infect dis 71(15): 762-768.
20. Rahman, A., et al. (2021). "Hematological abnormalities in COVID-19: a narrative review." The American journal of tropical medicine and hygiene 104(4): 1188.
21. Raj, V. S., et al. (2013). "Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC." Nature 495(7440): 251-254.
22. Russo, A., et al. (2022). "Implication of COVID-19 on erythrocytes functionality: red blood cell biochemical implications and morpho-functional aspects." International journal of molecular sciences 23(4): 2171.
23. Sharafi, F., et al. (2023). "Leukopenia and leukocytosis as strong predictors of COVID‐19 severity: A cross‐sectional study of the hematologic abnormalities and COVID‐19 severity in hospitalized patients." Health Science Reports 6(10): e1574.
24. Wan, S., et al. (2020). "Clinical features and treatment of COVID‐19 patients in northeast Chongqing." Journal of medical virology 92(7): 797-806.
25. Wang, Z., et al. (2020). "Clinical features of 69 cases with coronavirus disease 2019 in Wuhan, China." Clinical infectious diseases 71(15): 769-777.
26. Yang, A.-P., et al. (2020). "The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients." International immunopharmacology 84: 106504.
27. Yun, H., et al. (2020). "Laboratory data analysis of novel coronavirus (COVID-19) screening in 2510 patients." Clinica chimica acta 507: 94-97.